CurrentRheuma
Get Weekly

Topic · page 45 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,761–1,800 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Rheumatology (Oxford)

    Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment

    Cross-sectional study

  2. J Rheumatol

    Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study

    Cohort study

  3. J Rheumatol

    Genome-Wide Sequencing Identified Rare Genetic Variants for Childhood-Onset Monogenic Lupus

    Cohort study

  4. J Rheumatol

    Effect of Communicative and Critical Health Literacy on Trust in Physicians Among Patients With Systemic Lupus Erythematosus (SLE): The TRUMP2-SLE Project

    Cross-sectional study

  5. Arthritis Care Res (Hoboken)

    Association of Hurried Communication and Low Patient Self‐Efficacy With Persistent Nonadherence to Lupus Medications

    Cohort study

  6. Rheumatology (Oxford)

    Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus

    Cohort study

  7. Rheumatology (Oxford)

    TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus

    Mechanistic study

  8. Arthritis Rheumatol

    A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

    Randomized controlled trial

  9. Arthritis Rheumatol

    Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II , Randomized, Double‐Blind , Placebo‐Controlled Trial

    Randomized controlled trial

  10. Arthritis Care Res (Hoboken)

    Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data

    Research article

  11. Rheumatology (Oxford)

    Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

    Mechanistic study

  12. Lupus

    Adherence to antimalarials and glucocorticoids treatment and its association with self-reported disease activity in systemic lupus erythematosus patients

    Cross-sectional study

  13. Clin Exp Rheumatol

    Characterisation of T and B cell receptor repertoire in patients with systemic lupus erythematosus

    Mechanistic study

  14. Rheumatology (Oxford)

    Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography

    Cross-sectional study

  15. Lupus

    Literature review of lupus nephritis From the Arabian Gulf region

    Research article

  16. J Rheumatol

    Evaluating the Threshold Score for Classification of Systemic Lupus Erythematosus Using the EULAR/ACR Criteria

    Cross-sectional study

  17. Lupus

    Association between early immunophenotypic changes and therapeutic response of belimumab in patients with systemic lupus erythematosus

    Mechanistic study

  18. Arthritis Care Res (Hoboken)

    Association of the Systemic Lupus International Collaborating Clinics Frailty Index and Damage Accrual in Longstanding Systemic Lupus Erythematosus

    Secondary analysis

  19. Arthritis Care Res (Hoboken)

    Using Patient‐Reported Health Data From Social Media to Identify Diverse Lupus Patients and Assess Their Symptom and Medication Expressions: A Feasibility Study

    Cross-sectional study

  20. Rheumatology (Oxford)

    Deep stratification by transcriptome molecular characters for precision treatment of patients with systemic lupus erythematosus

    Mechanistic study

  21. Lupus

    U-KIM-1 as a predictor of treatment response in lupus nephritis

    Research article

  22. Lupus

    Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register

    Cross-sectional study

  23. Semin Arthritis Rheum

    Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus

    Cohort study

  24. Rheumatology (Oxford)

    The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study

    Cohort study

  25. Rheumatology (Oxford)

    COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance

    Meta-analysis

  26. Lupus

    Social determinants of depression in systemic lupus erythematosus: A systematic scoping review

    Research article

  27. Semin Arthritis Rheum

    Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Cohort study

  28. Arthritis Care Res (Hoboken)

    Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus

    Cohort study

  29. Rheumatology (Oxford)

    Grit personality of physicians and achievement of treatment goals in patients with system lupus erythematosus

    Cross-sectional study

  30. Ann Rheum Dis

    Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study

    Meta-analysis

  31. Rheumatology (Oxford)

    Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events

    Cohort study

  32. Clin Exp Rheumatol

    Low serum lipocalin-2 in pregnant women with systemic lupus erythematosus

    Cohort study

  33. Arthritis Care Res (Hoboken)

    Polypharmacy and Potentially Inappropriate Medication Use in Older Adults With Systemic Lupus Erythematosus

    Cross-sectional study

  34. Clin Exp Rheumatol

    Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosis

    Cross-sectional study

  35. Ann Rheum Dis

    Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports

    Cohort study

  36. Rheumatology (Oxford)

    Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study

    Cohort study

  37. Rheumatology (Oxford)

    Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases

    Cohort study

  38. Rheumatology (Oxford)

    Trust in the attending rheumatologist, health-related hope and medication adherence among Japanese systemic lupus erythematosus patients

    Cross-sectional study

  39. Lupus

    Pilot study on accelerated aging in lupus using epigenetic biomarkers of age

    Secondary analysis

  40. Rheumatology (Oxford)

    Association of mycophenolate and azathioprine use with cognitive function in systemic lupus

    Cohort study

All 1,848 Briefs in ExploreShowing Briefs 1,761–1,800 of 1,848, newest first